US Purchases 1.4M More Courses Of Merck’s Molnupiravir For $1B

Reuters (11/9, Mishra) reports, “Merck & Co Inc and partner Ridgeback Biotherapeutics said on Tuesday the U.S. government would pay about $1 billion to buy an additional 1.4 million courses of their COVID-19 pill,” bringing the US’ total purchase to 3.1 m...